Literature DB >> 19371270

Hepatitis A seroprevalence and demographics in Turkish children in Ankara.

Rukiye U Sac1, Ilknur Bostanci, Yildiz Dallar, Goksin Cihan, Ozlem Atli.   

Abstract

BACKGROUND: Hepatitis A virus (HAV) is the most common cause of hepatitis in childhood and an important public health problem. The objective of the present study was to determine the seroprevalence of hepatitis A and patient demographics in children between 1 and 15 years old who were admitted to a pediatric outpatient clinic in Ankara, Turkey.
METHODS: Hepatitis IgM and G antibodies were determined in the sera of children who attended the outpatient clinic. Informed consent was obtained from all subjects or their parents.
RESULTS: The mean age of the children (n = 335) was 7.9 +/- 2.1 years; 47.5% of them were girls. The overall anti-HAV IgG prevalence in children aged 1-15 years was 47.2%. The positivity of hepatitis A IgM was highest in the 6-10 years age group (22.7%; P < 0.001). HAV IgG was highest in the 11-15 years age group (69.4%; P < 0.001). A total of 95.6% of the children had social insurance, 49.3% were living in poverty. The socioeconomic level of 82.4% of subjects was low. The history of hepatitis in their families was 6.9%.
CONCLUSIONS: Hepatitis A is intermediate endemic in Ankara and children must be vaccinated before school age, in addition to health education and improved sanitation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371270     DOI: 10.1111/j.1442-200X.2008.02671.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  4 in total

1.  Shifting epidemiology of hepatitis a infection and vaccination status of children aged 6 months-12 years: time for mass vaccination.

Authors:  Burcin Nalbantoglu; Metin M Donma; Burcu Ozdilek; Erkut Karasu; Aysin Nalbantoglu
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

2.  Determinants of anti-hepatitis A antibody seroprevalence in 2- to 19-year-olds in the USA using NHANES 2007-2008.

Authors:  E Velasco-Mondragon; I Lindong; F Kamangar
Journal:  Epidemiol Infect       Date:  2011-05-09       Impact factor: 2.451

Review 3.  A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Authors:  Selim Badur; Serdar Öztürk; Alev Ozakay; Mansour Khalaf; Debasish Saha; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

4.  Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey.

Authors:  Necla Tulek; Metin Ozsoy; Cigdem Moroglu; Meliha Cagla Sonmezer; Fatih Temocin; Gunay Tuncer Ertem; Fatma Sebnem Erdinc
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.